Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.25.1 (
proteasome
)
28,817
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Extracellular signal-regulated kinase 3
(
ERK3
) is an unstable mitogen-activated protein kinase homologue that is constitutively degraded by the ubiquitin-
proteasome
pathway in proliferating cells. Here we show that a lysineless mutant of
ERK3
is still ubiquitinated in vivo and requires a functional ubiquitin conjugation pathway for its degradation. Addition of N-terminal sequence tags of increasing size stabilizes
ERK3
by preventing its ubiquitination. Importantly, we identified a fusion peptide between the N-terminal methionine of
ERK3
and the C-terminal glycine of ubiquitin in vivo by tandem mass spectrometry analysis. These findings demonstrate that
ERK3
is conjugated to ubiquitin via its free NH(2) terminus. We found that large N-terminal tags also stabilize the expression of the cell cycle inhibitor p21 but not that of substrates ubiquitinated on internal lysine residues. Consistent with this observation, lysineless p21 is ubiquitinated and degraded in a ubiquitin-dependent manner in intact cells. Our results suggests that N-terminal ubiquitination is a more prevalent modification than originally recognized.
...
PMID:N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome. 1522 18
Extracellular signal-regulated kinase 3
(
ERK3
) is an atypical mitogen-activated protein kinase (MAPK) whose regulatory mechanisms and biological functions remain superficially understood. Contrary to most protein kinases,
ERK3
is a highly unstable protein that is subject to dynamic regulation by the ubiquitin-
proteasome
system. However, the effectors that control
ERK3
ubiquitination and degradation are unknown. In this study, we carried out an unbiased functional loss-of-function screen of the human deubiquitinating enzyme (DUB) family and identified ubiquitin-specific protease 20 (USP20) as a novel
ERK3
regulator. USP20 interacts with and deubiquitinates
ERK3
both
in vitro
and in intact cells. The overexpression of USP20 results in the stabilization and accumulation of the
ERK3
protein, whereas USP20 depletion reduces the levels of
ERK3
. We found that the expression levels of
ERK3
correlate with those of USP20 in various cellular contexts. Importantly, we show that USP20 regulates actin cytoskeleton organization and cell migration in a manner dependent on
ERK3
expression. Our results identify USP20 as a bona fide regulator of
ERK3
stability and physiological functions.
...
PMID:Deubiquitinating Enzyme USP20 Regulates Extracellular Signal-Regulated Kinase 3 Stability and Biological Activity. 2816 6